A detailed history of Sg Americas Securities, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sg Americas Securities, LLC holds 46,172 shares of LLY stock, worth $36 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
46,172
Previous 27,108 70.33%
Holding current value
$36 Million
Previous $24.5 Million 66.67%
% of portfolio
0.15%
Previous 0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$772.14 - $960.02 $14.7 Million - $18.3 Million
19,064 Added 70.33%
46,172 $40.9 Million
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $111 Million - $139 Million
-153,083 Reduced 84.96%
27,108 $24.5 Million
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $92.1 Million - $123 Million
155,592 Added 632.51%
180,191 $140 Million
Q4 2023

Jan 12, 2024

SELL
$525.19 - $619.13 $57 Million - $67.2 Million
-108,520 Reduced 81.52%
24,599 $14.3 Million
Q3 2023

Oct 13, 2023

BUY
$434.7 - $599.3 $43.8 Million - $60.3 Million
100,675 Added 310.3%
133,119 $71.5 Million
Q2 2023

Jul 10, 2023

SELL
$350.74 - $468.98 $27 Million - $36.1 Million
-76,939 Reduced 70.34%
32,444 $15.2 Million
Q1 2023

Apr 28, 2023

BUY
$310.63 - $364.82 $31.3 Million - $36.7 Million
100,638 Added 1150.81%
109,383 $37.6 Million
Q4 2022

Feb 02, 2023

SELL
$321.55 - $374.67 $3.97 Million - $4.63 Million
-12,351 Reduced 58.55%
8,745 $3.2 Million
Q3 2022

Oct 31, 2022

SELL
$296.48 - $337.87 $2.39 Million - $2.72 Million
-8,050 Reduced 27.62%
21,096 $6.82 Million
Q2 2022

Jul 29, 2022

BUY
$278.73 - $327.27 $3.69 Million - $4.34 Million
13,249 Added 83.34%
29,146 $9.45 Million
Q1 2022

Apr 29, 2022

SELL
$234.69 - $291.66 $8.71 Million - $10.8 Million
-37,107 Reduced 70.01%
15,897 $4.55 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $8.81 Million - $10.9 Million
39,193 Added 283.78%
53,004 $14.6 Million
Q3 2021

Nov 01, 2021

SELL
$221.6 - $272.71 $6.63 Million - $8.15 Million
-29,903 Reduced 68.41%
13,811 $3.19 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $16.2 Million - $21 Million
-89,765 Reduced 67.25%
43,714 $10 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $17 Million - $22 Million
103,371 Added 343.33%
133,479 $24.9 Million
Q4 2020

Feb 04, 2021

SELL
$130.46 - $172.63 $2.4 Million - $3.17 Million
-18,378 Reduced 37.9%
30,108 $5.08 Million
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $5.33 Million - $6.17 Million
36,455 Added 303.01%
48,486 $7.18 Million
Q2 2020

Jul 20, 2020

SELL
$136.42 - $164.18 $7.63 Million - $9.19 Million
-55,963 Reduced 82.31%
12,031 $1.98 Million
Q1 2020

Apr 30, 2020

BUY
$119.05 - $147.35 $7.52 Million - $9.31 Million
63,191 Added 1315.66%
67,994 $9.43 Million
Q4 2019

Jan 28, 2020

SELL
$106.92 - $132.43 $15.8 Million - $19.5 Million
-147,371 Reduced 96.84%
4,803 $631,000
Q3 2019

Nov 04, 2019

BUY
$106.79 - $116.16 $5.37 Million - $5.84 Million
50,274 Added 49.34%
152,174 $17 Million
Q2 2019

Jul 29, 2019

BUY
$110.79 - $129.32 $8.61 Million - $10.1 Million
77,755 Added 322.03%
101,900 $11.3 Million
Q1 2019

Apr 29, 2019

SELL
$111.31 - $131.02 $9.14 Million - $10.8 Million
-82,116 Reduced 77.28%
24,145 $3.13 Million
Q4 2018

Feb 01, 2019

SELL
$105.9 - $118.64 $6.57 Million - $7.36 Million
-62,013 Reduced 36.85%
106,261 $12.3 Million
Q3 2018

Nov 06, 2018

BUY
$85.86 - $107.31 $11.2 Million - $14 Million
130,637 Added 347.1%
168,274 $18.1 Million
Q2 2018

Aug 07, 2018

SELL
$75.7 - $86.88 $4.94 Million - $5.67 Million
-65,212 Reduced 63.41%
37,637 $3.21 Million
Q1 2018

May 03, 2018

SELL
$74.21 - $87.6 $6.27 Million - $7.41 Million
-84,542 Reduced 45.12%
102,849 $7.96 Million
Q4 2017

Jan 24, 2018

BUY
$81.94 - $87.89 $13.8 Million - $14.9 Million
169,020 Added 920.04%
187,391 $15.8 Million
Q3 2017

Nov 07, 2017

BUY
$77.07 - $85.54 $1.42 Million - $1.57 Million
18,371
18,371 $1.57 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.